ArticleJournal of neuroscience research2016

An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats.

Jennifer F Iaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.